Is CBD Legal in Washington, DC? Washington, DC Cannabis, Hemp, and CBD Laws (2026)

CBD can be obtained through Washington, D.C.’s licensed medical cannabis system, but hemp-derived CBD should not be described as an unrestricted ordinary retail product in the District. The federal hemp exemption and D.C.’s local cannabis definition are different. Official District legal analysis expressly addresses hemp-derived CBD as cannabis.

This guide concerns Washington, D.C., not Washington state. Buyers should distinguish licensed medical access, the limited personal-possession permissions under Initiative 71, and separate federal requirements. Our U.S. CBD legality guide explains the national framework.

Why the Federal Hemp Rule Does Not Settle D.C. CBD Law

The District’s controlled-substance definitions include cannabis, marijuana, and hashish without a general hemp exclusion. In a memorandum dated April 28, 2021, the Office of the Attorney General concluded that CBD, including hemp-derived CBD, falls within the District’s cannabis definition. Its classification depends on the plant material from which it is obtained.

The memorandum explains that the 2018 Farm Bill did not require D.C. to permit local hemp-CBD sales or possession merely because qualifying hemp was removed from federal marijuana control. Protection for interstate transportation through a jurisdiction is a different issue from authorization for local retail sales.

Recent enforcement reinforces why shoppers should not rely on blanket retail assurances. A 2026 ABCA settlement involving District Hemp Botanicals expressly bars that respondent from selling cannabis products, including hemp and CBD, in the District without a medical cannabis retail license. This is a case-specific settlement, but it is inconsistent with the claim that all hemp CBD may simply be sold like an ordinary consumer good.

For a particular formulation or proposed business activity, confirm the applicable District requirements with ABCA. A low-THC laboratory result or an out-of-state supplier’s shipping policy is not a local sales authorization.

Licensed Medical Access for D.C. Residents

The Alcoholic Beverage and Cannabis Administration’s patient page explains registration. Residents 21 and older may self-certify for medical use. Residents 20 and younger need a healthcare recommendation, and minor patients require an adult caregiver.

Resident applicants receive a temporary digital registration valid for 90 days while the application is reviewed. Following approval, new registrations are valid for two years. Bring the required identification as well as the registration when purchasing.

ABCA introduced a new customer portal in August 2026. Applications submitted in the legacy system before 8 a.m. on August 18 remain there rather than transferring automatically. Use the links on ABCA’s current patient page to find the correct system and track an application or allotment.

The current fee schedule says initial and renewal resident patient and caregiver digital-registration fees are waived; an optional physical card costs $10. Older six-year registrations issued before March 2, 2025 remain valid until their displayed expiration date.

Visitors Can Use the Medical Program Too

ABCA offers non-resident registration for adults 21 and older, including international visitors. It also accepts qualifying medical registrations from jurisdictions with reciprocity. Check eligibility rather than assuming any out-of-state card is sufficient.

The visitor fee schedule lists registrations for three days ($10), thirty days ($20), ninety days ($50), 180 days ($75), and 365 days ($100). Non-resident self-certification and registration requirements differ from the resident application process.

Permission to buy in the District does not authorize taking cannabis across a state or international border. Plan the purchase and any travel separately.

Purchase Limits and Personal Possession

ABCA states that registered patients may purchase up to eight ounces of medical cannabis within a rolling thirty-day period. This is a tracked program allowance, not a new allowance every time a patient changes retailers.

For nonmedical marijuana, Initiative 71 guidance describes limited permissions for adults 21 and older: possession of up to two ounces, home cultivation of up to six plants with no more than three mature, and transfer of up to one ounce to another adult without payment. These permissions do not establish a recreational retail market.

Do not apply a dried-marijuana limit mechanically to a CBD concentrate or assume hemp CBD has an unlimited local possession exemption. The District’s definitions distinguish marijuana and resin-derived products, and medical-program permissions are separate. Public consumption and impaired driving remain prohibited.

Gifting Shops Are Not a Substitute for a License

The District’s Initiative 71 fact sheet makes clear that the initiative did not legalize marijuana sales. Calling cannabis a gift while tying it to another purchase does not by itself create a lawful retail transaction.

Use ABCA’s current licensed-retailer information when seeking medical cannabis or CBD-containing cannabis products. A shop’s past operation, familiar branding, or claim of Initiative 71 compliance does not establish that it holds a current medical cannabis retail license.

Federal Food and Medicine Requirements

The FDA prohibits marketing CBD as a dietary supplement and generally prohibits introducing foods with added CBD into interstate commerce. Qualifying as federal hemp does not waive these rules or approve medical claims.

Epidiolex is FDA-approved prescription cannabidiol for specified seizure disorders. Its approval does not apply to other retail CBD products. Likewise, the federal rule effective April 28, 2026 places covered FDA-approved marijuana medicines and state-licensed medical marijuana, including covered District licensing, in Schedule III while retaining registration and other controls. Recreational marijuana remains in Schedule I.

Local permissions do not override federal-property restrictions. Check the rules of the specific location; a D.C. registration or lawful local purchase is not a universal permission to possess or consume cannabis on federal property.

The Two Federal Hemp Deadlines

Section 781 of Public Law 119-37 changes the federal hemp definition. The September 2026 extension in Section 2019 delays most amendments until December 11, 2026. November 12 remains the start for exclusions covering intermediate and final products containing cannabinoids the cannabis plant cannot naturally produce.

The December provisions include a total-THC definition counting THCA, exclusions for naturally producible cannabinoids synthesized or manufactured outside the plant, and exclusion of finished products above 0.4 mg per container of combined total THC and specified similarly acting cannabinoids. This is a whole-container threshold, not a per-serving allowance or a limit on CBD itself.

A full-spectrum product can be affected even when marketed as non-intoxicating. The federal extension does not relax existing D.C. requirements or create an ordinary-retail CBD exemption.

Before Buying a CBD Product

Confirm the seller’s authorization and the exact product’s legal route. Match the batch number to a current laboratory report, checking CBD, THC, and other cannabinoids. A report helps identify contents; it does not replace licensing, drug approval, or legal compliance.

The national supplier listings below are provided for product research. They should not be read as confirmation that those sellers or every item they offer are authorized for sale or delivery in Washington, D.C. Use the District’s official guidance before ordering.